14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days kr261.50 kr388.50 Friday, 3rd May 2024 XVIVO.ST stock ended at kr378.00. This is 2.02% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.15% from a day low at kr372.00 to a day high of kr380.00.
90 days kr252.50 kr388.50
52 weeks kr205.50 kr388.50

Historical Xvivo Perfusion AB (publ) prices

Date Open High Low Close Volume
May 03, 2024 kr380.00 kr380.00 kr372.00 kr378.00 83 930
May 02, 2024 kr384.00 kr388.50 kr367.00 kr370.50 64 307
Apr 30, 2024 kr378.50 kr385.00 kr373.50 kr379.00 37 621
Apr 29, 2024 kr372.50 kr380.00 kr365.00 kr377.00 46 780
Apr 26, 2024 kr361.50 kr377.00 kr361.00 kr373.00 64 038
Apr 25, 2024 kr362.50 kr370.50 kr343.50 kr356.50 107 553
Apr 24, 2024 kr351.50 kr378.50 kr351.50 kr368.50 250 812
Apr 23, 2024 kr314.00 kr322.50 kr311.50 kr321.00 28 142
Apr 22, 2024 kr316.50 kr321.00 kr312.00 kr314.00 19 297
Apr 19, 2024 kr318.00 kr323.00 kr314.00 kr316.50 27 128
Apr 18, 2024 kr327.00 kr327.00 kr317.00 kr321.00 40 414
Apr 17, 2024 kr324.50 kr330.50 kr320.00 kr328.00 28 473
Apr 16, 2024 kr328.00 kr333.50 kr322.50 kr324.50 94 603
Apr 15, 2024 kr324.00 kr338.50 kr323.00 kr332.00 71 053
Apr 12, 2024 kr322.00 kr333.00 kr322.00 kr323.50 89 823
Apr 11, 2024 kr285.50 kr322.50 kr284.50 kr319.00 213 467
Apr 10, 2024 kr283.00 kr295.00 kr279.00 kr285.50 65 576
Apr 09, 2024 kr284.00 kr288.00 kr279.00 kr281.00 28 172
Apr 08, 2024 kr281.00 kr288.00 kr273.00 kr284.50 46 714
Apr 05, 2024 kr271.00 kr287.50 kr270.50 kr280.00 74 626
Apr 04, 2024 kr264.50 kr272.00 kr263.00 kr271.00 88 234
Apr 03, 2024 kr266.00 kr268.50 kr261.50 kr264.50 56 870
Apr 02, 2024 kr276.00 kr278.50 kr264.50 kr266.50 56 901
Mar 28, 2024 kr275.00 kr276.50 kr271.50 kr275.00 8 882
Mar 27, 2024 kr273.00 kr277.00 kr273.00 kr275.00 13 595
Click to get the best stock tips daily for free!

About Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lu... XVIVO.ST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT